Home » Topics » Conferences

Conferences
RSS

Profile of ZD-4190, a potent VEGF receptor tyrosine kinase inhibitor and antiangiogenic agent

April 15, 1999

In vitro and in vivo antitumor effects of noscapine discussed at AACR meeting

April 15, 1999

Novel water-soluble camptothecin analogue suitable for formulation in liposomes

April 15, 1999

Sugen presents preclinical data for SU-6668 at AACR meeting

April 15, 1999

PEG-rMETase, a promising new approach to cancer therapy

April 15, 1999

Potent and specific FTase inhibitor presented by Biomeasure

April 15, 1999

Merck presents protein farnesyltransferase inhibitor in phase I testing

April 15, 1999

Substituted purines and pyrimidines as inhibitors of cyclin-dependent kinases

April 14, 1999

Farnesyltransferase inhibitors especially effective in combination with other chemotherapeutic drugs

April 14, 1999

CL-387785: covalent, irreversible inhibitor of EGF and related receptor tyrosine kinases

April 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.